SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-21-019812
Filing Date
2021-08-13
Accepted
2021-08-13 17:28:45
Documents
5

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 306346
2 ex5-1.htm EX-5.1 16993
3 ex23-1.htm EX-23.1 4937
4 logo_001.jpg GRAPHIC 14609
5 ex5-1_001.jpg GRAPHIC 2500
  Complete submission text file 0001493152-21-019812.txt   353331
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258825 | Film No.: 211173491
SIC: 7389 Services-Business Services, NEC